Authors : Joseph Lemaitre, Désirée Popelka, Blandine Ribotta, Hannah Westlake, Sveta Chakrabarti, Li Xiaoxue, Mark A. Hanson, Haobo Jiang, Francesca Di Cara, Estee Kurant, Fabrice David, Bruno Lemaitre
The ReproSci project retrospectively analyzed the reproducibility of 1006 claims from 400 papers published between 1959 and 2011 in the field of Drosophila immunity. This project attempts to provide a comprehensive assessment, 14 years later, of the replicability of nearly all publications across an entire scientific community in experimental life sciences.
We found that 61% of claims were verified, while only 7% were directly challenged (not reproducible), a replicability rate higher than previous assessments. Notably, 24% of claims had never been independently tested and remain unchallenged.
We performed experimental validations of a selection of 45 unchallenged claim, that revealed that a significant fraction (38/45) of them is in fact non-reproducible. We also found that high-impact journals and top-ranked institutions are more likely to publish challenged claims.
In line with the reproducibility crisis narrative, the rates of both challenged and unchallenged claims increased over time, especially as the field gained popularity. We characterized the uneven distribution of irreproducibility among first and last authors.
Surprisingly, irreproducibility rates were similar between PhD students and postdocs, and did not decrease with experience or publication count. However, group leaders, who had prior experience as first authors in another Drosophila immunity team, had lower irreproducibility rates, underscoring the importance of early-career training.
Finally, authors with a more exploratory, short-term engagement with the field exhibited slightly higher rates of challenged claims and a markedly higher proportion of unchallenged ones. This systematic, field-wide retrospective study offers meaningful insights into the ongoing discussion on reproducibility in experimental life sciences.